Xian-Janssen taps DMG for AOR duties on Gyno-Daktarin

Xian-Janssen Pharmaceutical (XJP), one of two JVs operated in China by Johnson & Johnson, has handed AOR reponsibilities for its Gyno-Daktarin brand to DMG after holding its first creative pitch in more than five years.

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now